Retatrutide : Phase 3 TRIUMPH-4 demonstrated 28.7% mean weight loss at 68 weeks with 12 mg dose (Phase 2 showed 24.2% at 48 weeks)
Together, they deliver intense moisture and restoration for a radiant, youthful look
Tabe Y, Hatanaka Y, Nakashiro M, Sekihara K, Yamamoto S, Matsushita H, Kazuno S, Sasai K, Iwabuchi K, Andreeff M , Konopleva M, Miida T
Eventually, Huntingtin aggregation interrupts the function of neurons, culminating into death of HD patients
What community members commonly report: Injection-site reactions (redness, swelling) expected with large-volume subcutaneous injections Mild flu-like symptoms in the 24-72 hours following injection, which some interpret as an immune response to senescent cell die-off Fatigue and general malaise lasting 1-3 days post-injection No noticeable positive effects yet What community members probably will NOT notice: Improved energy or vitality Visible changes in skin, hair, or physical appearance Measurable changes in bloodwork Any performance enhancement Realistic expectation: Week 1 is about initiating the senolytic process
